TherapeuticsMD (TXMD) Misses Q1 EPS by $1.69

TherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($5.69), $1.69 worse than the analyst estimate of ($4.00). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $17.95 million.

For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c